Elena Shvets

Dr. Elena Shvets is a Principal Scientist at Sphere Fluidics Ltd, UK, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology. After finishing her PhD in the Weizmann Institute of Science, Israel, focusing on autophagy, Elena moved to postdoctoral studies in MRC-LMB, Cambridge, UK, to work on membrane trafficking and endocytosis. As part of her research, she used several genome-editing tools such as TALENs and CRISPR-Cas9 to manipulate mammalian cell genome by deleting or tagging multiple cell membrane proteins. Since joining Sphere Fluidics 5 years ago, Elena works across multiple areas of R&D, including assay development, antibody discovery, and cell line development. She has also worked as the primary technical lead and project manager in two grants funded by Innovate UK and Eurostars Eureka to apply picodroplets technology in cell engineering and genome editing. Her particular interest lies in consolidating steps in the cell engineering workflow into an all-in-one automated solution to manipulate, screen, and isolate rare positive clones of edited cells.